Geneos Wealth Management’s Organigram Holdings OGI Stock Holding History

Geneos Wealth Management’s Portfolio OGI Stock Details OGI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-2,000	Closed	-$7K	–	2413
2022 Q2	$7K	Hold	2,000	–	–	﹤0.01%	2087
2022 Q1	$13K	Hold	2,000	–	–	﹤0.01%	1977
2021 Q4	$14K	Hold	2,000	–	–	﹤0.01%	2049
2021 Q3	$18K	Hold	2,000	–	–	﹤0.01%	1978
2021 Q2	$21K	Sell	2,000 -10	-0.5%	-$114	﹤0.01%	1896
2021 Q1	$21K	Hold	2,010	–	–	﹤0.01%	2062
2020 Q4	$28K	Sell	2,010 -70	-3%	-$359	﹤0.01%	1731
2020 Q3	$8K	Hold	2,080	–	–	﹤0.01%	2033
2020 Q2	$13K	Hold	2,080	–	–	﹤0.01%	1807
2020 Q1	$17K	Hold	2,080	–	–	﹤0.01%	1583
2019 Q4	$19K	Hold	2,080	–	–	﹤0.01%	1709
2019 Q3	$30K	Buy	2,080 +830	+66%	+$17.5K	﹤0.01%	1428
2019 Q2	$32K	Buy	+1,250	New	+$34.7K	﹤0.01%	1411

Other funds holding OGI

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

Merlin Capital Newport, Rhode Island $33.5M AUM 36.34% 1-Year Est. Return

IIM

Intact Investment Management Montreal, Quebec, Canada $3.52B AUM 37.29% 1-Year Est. Return

AdvisorShares Investments Bethesda, Maryland $549M AUM 32.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geneos Wealth Management's OGI Position: Q3 2022 in Review

Geneos Wealth Management sold out of Organigram Holdings (OGI) in Q3 2022, closing a stake of 2,000 shares — an estimated $7K sold.

Geneos Wealth Management first reported a position in OGI in Q2 2019 and held it in 13 quarters. The position peaked at $32K in Q2 2019. 120 funds tracked by Wall St. Rank hold OGI as of Q3 2022.

Geneos Wealth Management reported no remaining Organigram Holdings position as of Q3 2022 after selling out during the quarter.
Geneos Wealth Management sold 2,000 Organigram Holdings shares in Q3 2022, an estimated $7K.
Geneos Wealth Management first reported a position in Organigram Holdings in Q2 2019 and held it in 13 quarters.
Geneos Wealth Management's Organigram Holdings position peaked at $32K in Q2 2019.
120 funds tracked by Wall St. Rank held Organigram Holdings as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.